Schulz-Quach C

Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

2 papers · ORCID

ArticlePsilocybin

Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.

Brudner RM, Kaczmarek E, Blainey MG +9

ArticleKetamine

A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study).

Rosenblat JD, deVries FE, Doyle Z +9